Human Immunoglobulin for Intravenous Injection Market, Global Outlook and Forecast 2022-2028
Human immunoglobulin for intravenous injection is a blood product used for intravenous injection, and its effects can last from 2 weeks to 3 months.
This report contains market size and forecasts of Human Immunoglobulin for Intravenous Injection in global, including the following market information:
Global Human Immunoglobulin for Intravenous Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Immunoglobulin for Intravenous Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Immunoglobulin for Intravenous Injection companies in 2021 (%)
The global Human Immunoglobulin for Intravenous Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Children Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Immunoglobulin for Intravenous Injection include Tiantan Biological, Taibang Biological, Shanghai Laishi, Hualan Biological, Zhenghua Shenghua, Yuanda shuyang, Weiguang Biological, Boya Biological and Nanyue Biological, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Immunoglobulin for Intravenous Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Immunoglobulin for Intravenous Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Immunoglobulin for Intravenous Injection Market Segment Percentages, by Type, 2021 (%)
Global Human Immunoglobulin for Intravenous Injection Market Segment Percentages, by Application, 2021 (%)
Global Human Immunoglobulin for Intravenous Injection Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Human Immunoglobulin for Intravenous Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Immunoglobulin for Intravenous Injection revenues share in global market, 2021 (%)
Key companies Human Immunoglobulin for Intravenous Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Immunoglobulin for Intravenous Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Human Immunoglobulin for Intravenous Injection in global, including the following market information:
Global Human Immunoglobulin for Intravenous Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Immunoglobulin for Intravenous Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Immunoglobulin for Intravenous Injection companies in 2021 (%)
The global Human Immunoglobulin for Intravenous Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Children Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Immunoglobulin for Intravenous Injection include Tiantan Biological, Taibang Biological, Shanghai Laishi, Hualan Biological, Zhenghua Shenghua, Yuanda shuyang, Weiguang Biological, Boya Biological and Nanyue Biological, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Immunoglobulin for Intravenous Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Immunoglobulin for Intravenous Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Immunoglobulin for Intravenous Injection Market Segment Percentages, by Type, 2021 (%)
- Children
- Adult
Global Human Immunoglobulin for Intravenous Injection Market Segment Percentages, by Application, 2021 (%)
- Disease Prevention
- Treatment
- Diagnosis
- Other
Global Human Immunoglobulin for Intravenous Injection Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Human Immunoglobulin for Intravenous Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Immunoglobulin for Intravenous Injection revenues share in global market, 2021 (%)
Key companies Human Immunoglobulin for Intravenous Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Immunoglobulin for Intravenous Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Tiantan Biological
- Taibang Biological
- Shanghai Laishi
- Hualan Biological
- Zhenghua Shenghua
- Yuanda shuyang
- Weiguang Biological
- Boya Biological
- Nanyue Biological
- Paisi feike
- Kangbao Biological
- Lvshizi
- Zhongyuan Ruide
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Human Immunoglobulin for Intravenous Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Immunoglobulin for Intravenous Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INJECTION OVERALL MARKET SIZE
2.1 Global Human Immunoglobulin for Intravenous Injection Market Size: 2021 VS 2028
2.2 Global Human Immunoglobulin for Intravenous Injection Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Immunoglobulin for Intravenous Injection Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Immunoglobulin for Intravenous Injection Players in Global Market
3.2 Top Global Human Immunoglobulin for Intravenous Injection Companies Ranked by Revenue
3.3 Global Human Immunoglobulin for Intravenous Injection Revenue by Companies
3.4 Global Human Immunoglobulin for Intravenous Injection Sales by Companies
3.5 Global Human Immunoglobulin for Intravenous Injection Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Immunoglobulin for Intravenous Injection Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Immunoglobulin for Intravenous Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Immunoglobulin for Intravenous Injection Players in Global Market
3.8.1 List of Global Tier 1 Human Immunoglobulin for Intravenous Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Immunoglobulin for Intravenous Injection Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Immunoglobulin for Intravenous Injection Market Size Markets, 2021 & 2028
4.1.2 Children
4.1.3 Adult
4.2 By Type - Global Human Immunoglobulin for Intravenous Injection Revenue & Forecasts
4.2.1 By Type - Global Human Immunoglobulin for Intravenous Injection Revenue, 2017-2022
4.2.2 By Type - Global Human Immunoglobulin for Intravenous Injection Revenue, 2023-2028
4.2.3 By Type - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
4.3 By Type - Global Human Immunoglobulin for Intravenous Injection Sales & Forecasts
4.3.1 By Type - Global Human Immunoglobulin for Intravenous Injection Sales, 2017-2022
4.3.2 By Type - Global Human Immunoglobulin for Intravenous Injection Sales, 2023-2028
4.3.3 By Type - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
4.4 By Type - Global Human Immunoglobulin for Intravenous Injection Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Immunoglobulin for Intravenous Injection Market Size, 2021 & 2028
5.1.2 Disease Prevention
5.1.3 Treatment
5.1.4 Diagnosis
5.1.5 Other
5.2 By Application - Global Human Immunoglobulin for Intravenous Injection Revenue & Forecasts
5.2.1 By Application - Global Human Immunoglobulin for Intravenous Injection Revenue, 2017-2022
5.2.2 By Application - Global Human Immunoglobulin for Intravenous Injection Revenue, 2023-2028
5.2.3 By Application - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
5.3 By Application - Global Human Immunoglobulin for Intravenous Injection Sales & Forecasts
5.3.1 By Application - Global Human Immunoglobulin for Intravenous Injection Sales, 2017-2022
5.3.2 By Application - Global Human Immunoglobulin for Intravenous Injection Sales, 2023-2028
5.3.3 By Application - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
5.4 By Application - Global Human Immunoglobulin for Intravenous Injection Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Immunoglobulin for Intravenous Injection Market Size, 2021 & 2028
6.2 By Region - Global Human Immunoglobulin for Intravenous Injection Revenue & Forecasts
6.2.1 By Region - Global Human Immunoglobulin for Intravenous Injection Revenue, 2017-2022
6.2.2 By Region - Global Human Immunoglobulin for Intravenous Injection Revenue, 2023-2028
6.2.3 By Region - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
6.3 By Region - Global Human Immunoglobulin for Intravenous Injection Sales & Forecasts
6.3.1 By Region - Global Human Immunoglobulin for Intravenous Injection Sales, 2017-2022
6.3.2 By Region - Global Human Immunoglobulin for Intravenous Injection Sales, 2023-2028
6.3.3 By Region - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.4.2 By Country - North America Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.4.3 US Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.4.4 Canada Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.4.5 Mexico Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.5.2 By Country - Europe Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.5.3 Germany Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.4 France Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.5 U.K. Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.6 Italy Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.7 Russia Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.8 Nordic Countries Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.9 Benelux Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.6.2 By Region - Asia Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.6.3 China Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6.4 Japan Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6.5 South Korea Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6.6 Southeast Asia Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6.7 India Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.7.2 By Country - South America Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.7.3 Brazil Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.7.4 Argentina Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.8.3 Turkey Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.8.4 Israel Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.8.5 Saudi Arabia Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.8.6 UAE Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Tiantan Biological
7.1.1 Tiantan Biological Corporate Summary
7.1.2 Tiantan Biological Business Overview
7.1.3 Tiantan Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.1.4 Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.1.5 Tiantan Biological Key News
7.2 Taibang Biological
7.2.1 Taibang Biological Corporate Summary
7.2.2 Taibang Biological Business Overview
7.2.3 Taibang Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.2.4 Taibang Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.2.5 Taibang Biological Key News
7.3 Shanghai Laishi
7.3.1 Shanghai Laishi Corporate Summary
7.3.2 Shanghai Laishi Business Overview
7.3.3 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.3.4 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.3.5 Shanghai Laishi Key News
7.4 Hualan Biological
7.4.1 Hualan Biological Corporate Summary
7.4.2 Hualan Biological Business Overview
7.4.3 Hualan Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.4.4 Hualan Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.4.5 Hualan Biological Key News
7.5 Zhenghua Shenghua
7.5.1 Zhenghua Shenghua Corporate Summary
7.5.2 Zhenghua Shenghua Business Overview
7.5.3 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.5.4 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.5.5 Zhenghua Shenghua Key News
7.6 Yuanda shuyang
7.6.1 Yuanda shuyang Corporate Summary
7.6.2 Yuanda shuyang Business Overview
7.6.3 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.6.4 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.6.5 Yuanda shuyang Key News
7.7 Weiguang Biological
7.7.1 Weiguang Biological Corporate Summary
7.7.2 Weiguang Biological Business Overview
7.7.3 Weiguang Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.7.4 Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.7.5 Weiguang Biological Key News
7.8 Boya Biological
7.8.1 Boya Biological Corporate Summary
7.8.2 Boya Biological Business Overview
7.8.3 Boya Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.8.4 Boya Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.8.5 Boya Biological Key News
7.9 Nanyue Biological
7.9.1 Nanyue Biological Corporate Summary
7.9.2 Nanyue Biological Business Overview
7.9.3 Nanyue Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.9.4 Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.9.5 Nanyue Biological Key News
7.10 Paisi feike
7.10.1 Paisi feike Corporate Summary
7.10.2 Paisi feike Business Overview
7.10.3 Paisi feike Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.10.4 Paisi feike Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.10.5 Paisi feike Key News
7.11 Kangbao Biological
7.11.1 Kangbao Biological Corporate Summary
7.11.2 Kangbao Biological Human Immunoglobulin for Intravenous Injection Business Overview
7.11.3 Kangbao Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.11.4 Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.11.5 Kangbao Biological Key News
7.12 Lvshizi
7.12.1 Lvshizi Corporate Summary
7.12.2 Lvshizi Human Immunoglobulin for Intravenous Injection Business Overview
7.12.3 Lvshizi Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.12.4 Lvshizi Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.12.5 Lvshizi Key News
7.13 Zhongyuan Ruide
7.13.1 Zhongyuan Ruide Corporate Summary
7.13.2 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Business Overview
7.13.3 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.13.4 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.13.5 Zhongyuan Ruide Key News
8 GLOBAL HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INJECTION PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Immunoglobulin for Intravenous Injection Production Capacity, 2017-2028
8.2 Human Immunoglobulin for Intravenous Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Immunoglobulin for Intravenous Injection Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INJECTION SUPPLY CHAIN ANALYSIS
10.1 Human Immunoglobulin for Intravenous Injection Industry Value Chain
10.2 Human Immunoglobulin for Intravenous Injection Upstream Market
10.3 Human Immunoglobulin for Intravenous Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Immunoglobulin for Intravenous Injection Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Human Immunoglobulin for Intravenous Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Immunoglobulin for Intravenous Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INJECTION OVERALL MARKET SIZE
2.1 Global Human Immunoglobulin for Intravenous Injection Market Size: 2021 VS 2028
2.2 Global Human Immunoglobulin for Intravenous Injection Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Immunoglobulin for Intravenous Injection Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Immunoglobulin for Intravenous Injection Players in Global Market
3.2 Top Global Human Immunoglobulin for Intravenous Injection Companies Ranked by Revenue
3.3 Global Human Immunoglobulin for Intravenous Injection Revenue by Companies
3.4 Global Human Immunoglobulin for Intravenous Injection Sales by Companies
3.5 Global Human Immunoglobulin for Intravenous Injection Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Immunoglobulin for Intravenous Injection Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Immunoglobulin for Intravenous Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Immunoglobulin for Intravenous Injection Players in Global Market
3.8.1 List of Global Tier 1 Human Immunoglobulin for Intravenous Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Immunoglobulin for Intravenous Injection Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Immunoglobulin for Intravenous Injection Market Size Markets, 2021 & 2028
4.1.2 Children
4.1.3 Adult
4.2 By Type - Global Human Immunoglobulin for Intravenous Injection Revenue & Forecasts
4.2.1 By Type - Global Human Immunoglobulin for Intravenous Injection Revenue, 2017-2022
4.2.2 By Type - Global Human Immunoglobulin for Intravenous Injection Revenue, 2023-2028
4.2.3 By Type - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
4.3 By Type - Global Human Immunoglobulin for Intravenous Injection Sales & Forecasts
4.3.1 By Type - Global Human Immunoglobulin for Intravenous Injection Sales, 2017-2022
4.3.2 By Type - Global Human Immunoglobulin for Intravenous Injection Sales, 2023-2028
4.3.3 By Type - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
4.4 By Type - Global Human Immunoglobulin for Intravenous Injection Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Immunoglobulin for Intravenous Injection Market Size, 2021 & 2028
5.1.2 Disease Prevention
5.1.3 Treatment
5.1.4 Diagnosis
5.1.5 Other
5.2 By Application - Global Human Immunoglobulin for Intravenous Injection Revenue & Forecasts
5.2.1 By Application - Global Human Immunoglobulin for Intravenous Injection Revenue, 2017-2022
5.2.2 By Application - Global Human Immunoglobulin for Intravenous Injection Revenue, 2023-2028
5.2.3 By Application - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
5.3 By Application - Global Human Immunoglobulin for Intravenous Injection Sales & Forecasts
5.3.1 By Application - Global Human Immunoglobulin for Intravenous Injection Sales, 2017-2022
5.3.2 By Application - Global Human Immunoglobulin for Intravenous Injection Sales, 2023-2028
5.3.3 By Application - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
5.4 By Application - Global Human Immunoglobulin for Intravenous Injection Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Immunoglobulin for Intravenous Injection Market Size, 2021 & 2028
6.2 By Region - Global Human Immunoglobulin for Intravenous Injection Revenue & Forecasts
6.2.1 By Region - Global Human Immunoglobulin for Intravenous Injection Revenue, 2017-2022
6.2.2 By Region - Global Human Immunoglobulin for Intravenous Injection Revenue, 2023-2028
6.2.3 By Region - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
6.3 By Region - Global Human Immunoglobulin for Intravenous Injection Sales & Forecasts
6.3.1 By Region - Global Human Immunoglobulin for Intravenous Injection Sales, 2017-2022
6.3.2 By Region - Global Human Immunoglobulin for Intravenous Injection Sales, 2023-2028
6.3.3 By Region - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.4.2 By Country - North America Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.4.3 US Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.4.4 Canada Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.4.5 Mexico Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.5.2 By Country - Europe Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.5.3 Germany Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.4 France Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.5 U.K. Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.6 Italy Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.7 Russia Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.8 Nordic Countries Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.5.9 Benelux Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.6.2 By Region - Asia Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.6.3 China Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6.4 Japan Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6.5 South Korea Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6.6 Southeast Asia Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.6.7 India Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.7.2 By Country - South America Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.7.3 Brazil Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.7.4 Argentina Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales, 2017-2028
6.8.3 Turkey Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.8.4 Israel Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.8.5 Saudi Arabia Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
6.8.6 UAE Human Immunoglobulin for Intravenous Injection Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Tiantan Biological
7.1.1 Tiantan Biological Corporate Summary
7.1.2 Tiantan Biological Business Overview
7.1.3 Tiantan Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.1.4 Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.1.5 Tiantan Biological Key News
7.2 Taibang Biological
7.2.1 Taibang Biological Corporate Summary
7.2.2 Taibang Biological Business Overview
7.2.3 Taibang Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.2.4 Taibang Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.2.5 Taibang Biological Key News
7.3 Shanghai Laishi
7.3.1 Shanghai Laishi Corporate Summary
7.3.2 Shanghai Laishi Business Overview
7.3.3 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.3.4 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.3.5 Shanghai Laishi Key News
7.4 Hualan Biological
7.4.1 Hualan Biological Corporate Summary
7.4.2 Hualan Biological Business Overview
7.4.3 Hualan Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.4.4 Hualan Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.4.5 Hualan Biological Key News
7.5 Zhenghua Shenghua
7.5.1 Zhenghua Shenghua Corporate Summary
7.5.2 Zhenghua Shenghua Business Overview
7.5.3 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.5.4 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.5.5 Zhenghua Shenghua Key News
7.6 Yuanda shuyang
7.6.1 Yuanda shuyang Corporate Summary
7.6.2 Yuanda shuyang Business Overview
7.6.3 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.6.4 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.6.5 Yuanda shuyang Key News
7.7 Weiguang Biological
7.7.1 Weiguang Biological Corporate Summary
7.7.2 Weiguang Biological Business Overview
7.7.3 Weiguang Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.7.4 Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.7.5 Weiguang Biological Key News
7.8 Boya Biological
7.8.1 Boya Biological Corporate Summary
7.8.2 Boya Biological Business Overview
7.8.3 Boya Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.8.4 Boya Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.8.5 Boya Biological Key News
7.9 Nanyue Biological
7.9.1 Nanyue Biological Corporate Summary
7.9.2 Nanyue Biological Business Overview
7.9.3 Nanyue Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.9.4 Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.9.5 Nanyue Biological Key News
7.10 Paisi feike
7.10.1 Paisi feike Corporate Summary
7.10.2 Paisi feike Business Overview
7.10.3 Paisi feike Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.10.4 Paisi feike Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.10.5 Paisi feike Key News
7.11 Kangbao Biological
7.11.1 Kangbao Biological Corporate Summary
7.11.2 Kangbao Biological Human Immunoglobulin for Intravenous Injection Business Overview
7.11.3 Kangbao Biological Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.11.4 Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.11.5 Kangbao Biological Key News
7.12 Lvshizi
7.12.1 Lvshizi Corporate Summary
7.12.2 Lvshizi Human Immunoglobulin for Intravenous Injection Business Overview
7.12.3 Lvshizi Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.12.4 Lvshizi Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.12.5 Lvshizi Key News
7.13 Zhongyuan Ruide
7.13.1 Zhongyuan Ruide Corporate Summary
7.13.2 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Business Overview
7.13.3 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Major Product Offerings
7.13.4 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales and Revenue in Global (2017-2022)
7.13.5 Zhongyuan Ruide Key News
8 GLOBAL HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INJECTION PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Immunoglobulin for Intravenous Injection Production Capacity, 2017-2028
8.2 Human Immunoglobulin for Intravenous Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Immunoglobulin for Intravenous Injection Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INJECTION SUPPLY CHAIN ANALYSIS
10.1 Human Immunoglobulin for Intravenous Injection Industry Value Chain
10.2 Human Immunoglobulin for Intravenous Injection Upstream Market
10.3 Human Immunoglobulin for Intravenous Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Immunoglobulin for Intravenous Injection Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Human Immunoglobulin for Intravenous Injection in Global Market
Table 2. Top Human Immunoglobulin for Intravenous Injection Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Immunoglobulin for Intravenous Injection Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Immunoglobulin for Intravenous Injection Revenue Share by Companies, 2017-2022
Table 5. Global Human Immunoglobulin for Intravenous Injection Sales by Companies, (K Units), 2017-2022
Table 6. Global Human Immunoglobulin for Intravenous Injection Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Immunoglobulin for Intravenous Injection Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Immunoglobulin for Intravenous Injection Product Type
Table 9. List of Global Tier 1 Human Immunoglobulin for Intravenous Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Immunoglobulin for Intravenous Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2017-2022
Table 15. By Type - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2023-2028
Table 16. By Application – Global Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2017-2022
Table 20. By Application - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2023-2028
Table 21. By Region – Global Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2017-2022
Table 25. By Region - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2023-2028
Table 26. By Country - North America Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 29. By Country - North America Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 30. By Country - Europe Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 33. By Country - Europe Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 34. By Region - Asia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 37. By Region - Asia Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 38. By Country - South America Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 41. By Country - South America Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 46. Tiantan Biological Corporate Summary
Table 47. Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 48. Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Taibang Biological Corporate Summary
Table 50. Taibang Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 51. Taibang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Shanghai Laishi Corporate Summary
Table 53. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Offerings
Table 54. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Hualan Biological Corporate Summary
Table 56. Hualan Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 57. Hualan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Zhenghua Shenghua Corporate Summary
Table 59. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Offerings
Table 60. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Yuanda shuyang Corporate Summary
Table 62. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Offerings
Table 63. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Weiguang Biological Corporate Summary
Table 65. Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 66. Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Boya Biological Corporate Summary
Table 68. Boya Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 69. Boya Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Nanyue Biological Corporate Summary
Table 71. Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 72. Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Paisi feike Corporate Summary
Table 74. Paisi feike Human Immunoglobulin for Intravenous Injection Product Offerings
Table 75. Paisi feike Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Kangbao Biological Corporate Summary
Table 77. Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 78. Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Lvshizi Corporate Summary
Table 80. Lvshizi Human Immunoglobulin for Intravenous Injection Product Offerings
Table 81. Lvshizi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Zhongyuan Ruide Corporate Summary
Table 83. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Offerings
Table 84. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Human Immunoglobulin for Intravenous Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Human Immunoglobulin for Intravenous Injection Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Human Immunoglobulin for Intravenous Injection Production by Region, 2017-2022 (K Units)
Table 88. Global Human Immunoglobulin for Intravenous Injection Production by Region, 2023-2028 (K Units)
Table 89. Human Immunoglobulin for Intravenous Injection Market Opportunities & Trends in Global Market
Table 90. Human Immunoglobulin for Intravenous Injection Market Drivers in Global Market
Table 91. Human Immunoglobulin for Intravenous Injection Market Restraints in Global Market
Table 92. Human Immunoglobulin for Intravenous Injection Raw Materials
Table 93. Human Immunoglobulin for Intravenous Injection Raw Materials Suppliers in Global Market
Table 94. Typical Human Immunoglobulin for Intravenous Injection Downstream
Table 95. Human Immunoglobulin for Intravenous Injection Downstream Clients in Global Market
Table 96. Human Immunoglobulin for Intravenous Injection Distributors and Sales Agents in Global Market
Table 1. Key Players of Human Immunoglobulin for Intravenous Injection in Global Market
Table 2. Top Human Immunoglobulin for Intravenous Injection Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Immunoglobulin for Intravenous Injection Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Immunoglobulin for Intravenous Injection Revenue Share by Companies, 2017-2022
Table 5. Global Human Immunoglobulin for Intravenous Injection Sales by Companies, (K Units), 2017-2022
Table 6. Global Human Immunoglobulin for Intravenous Injection Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Immunoglobulin for Intravenous Injection Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Immunoglobulin for Intravenous Injection Product Type
Table 9. List of Global Tier 1 Human Immunoglobulin for Intravenous Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Immunoglobulin for Intravenous Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2017-2022
Table 15. By Type - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2023-2028
Table 16. By Application – Global Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2017-2022
Table 20. By Application - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2023-2028
Table 21. By Region – Global Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Immunoglobulin for Intravenous Injection Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2017-2022
Table 25. By Region - Global Human Immunoglobulin for Intravenous Injection Sales (K Units), 2023-2028
Table 26. By Country - North America Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 29. By Country - North America Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 30. By Country - Europe Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 33. By Country - Europe Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 34. By Region - Asia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 37. By Region - Asia Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 38. By Country - South America Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 41. By Country - South America Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales, (K Units), 2023-2028
Table 46. Tiantan Biological Corporate Summary
Table 47. Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 48. Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Taibang Biological Corporate Summary
Table 50. Taibang Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 51. Taibang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Shanghai Laishi Corporate Summary
Table 53. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Offerings
Table 54. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Hualan Biological Corporate Summary
Table 56. Hualan Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 57. Hualan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Zhenghua Shenghua Corporate Summary
Table 59. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Offerings
Table 60. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Yuanda shuyang Corporate Summary
Table 62. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Offerings
Table 63. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Weiguang Biological Corporate Summary
Table 65. Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 66. Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Boya Biological Corporate Summary
Table 68. Boya Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 69. Boya Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Nanyue Biological Corporate Summary
Table 71. Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 72. Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Paisi feike Corporate Summary
Table 74. Paisi feike Human Immunoglobulin for Intravenous Injection Product Offerings
Table 75. Paisi feike Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Kangbao Biological Corporate Summary
Table 77. Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Offerings
Table 78. Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Lvshizi Corporate Summary
Table 80. Lvshizi Human Immunoglobulin for Intravenous Injection Product Offerings
Table 81. Lvshizi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Zhongyuan Ruide Corporate Summary
Table 83. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Offerings
Table 84. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Human Immunoglobulin for Intravenous Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Human Immunoglobulin for Intravenous Injection Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Human Immunoglobulin for Intravenous Injection Production by Region, 2017-2022 (K Units)
Table 88. Global Human Immunoglobulin for Intravenous Injection Production by Region, 2023-2028 (K Units)
Table 89. Human Immunoglobulin for Intravenous Injection Market Opportunities & Trends in Global Market
Table 90. Human Immunoglobulin for Intravenous Injection Market Drivers in Global Market
Table 91. Human Immunoglobulin for Intravenous Injection Market Restraints in Global Market
Table 92. Human Immunoglobulin for Intravenous Injection Raw Materials
Table 93. Human Immunoglobulin for Intravenous Injection Raw Materials Suppliers in Global Market
Table 94. Typical Human Immunoglobulin for Intravenous Injection Downstream
Table 95. Human Immunoglobulin for Intravenous Injection Downstream Clients in Global Market
Table 96. Human Immunoglobulin for Intravenous Injection Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Human Immunoglobulin for Intravenous Injection Segment by Type
Figure 2. Human Immunoglobulin for Intravenous Injection Segment by Application
Figure 3. Global Human Immunoglobulin for Intravenous Injection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Immunoglobulin for Intravenous Injection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Immunoglobulin for Intravenous Injection Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Immunoglobulin for Intravenous Injection Revenue in 2021
Figure 9. By Type - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Immunoglobulin for Intravenous Injection Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Immunoglobulin for Intravenous Injection Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 19. US Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 24. Germany Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 33. China Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 40. Brazil Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 44. Turkey Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Immunoglobulin for Intravenous Injection Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Human Immunoglobulin for Intravenous Injection by Region, 2021 VS 2028
Figure 50. Human Immunoglobulin for Intravenous Injection Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Human Immunoglobulin for Intravenous Injection Segment by Type
Figure 2. Human Immunoglobulin for Intravenous Injection Segment by Application
Figure 3. Global Human Immunoglobulin for Intravenous Injection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Immunoglobulin for Intravenous Injection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Immunoglobulin for Intravenous Injection Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Immunoglobulin for Intravenous Injection Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Immunoglobulin for Intravenous Injection Revenue in 2021
Figure 9. By Type - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Immunoglobulin for Intravenous Injection Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Immunoglobulin for Intravenous Injection Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 19. US Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 24. Germany Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 33. China Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 40. Brazil Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Immunoglobulin for Intravenous Injection Sales Market Share, 2017-2028
Figure 44. Turkey Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Immunoglobulin for Intravenous Injection Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Immunoglobulin for Intravenous Injection Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Human Immunoglobulin for Intravenous Injection by Region, 2021 VS 2028
Figure 50. Human Immunoglobulin for Intravenous Injection Industry Value Chain
Figure 51. Marketing Channels
